glp-1 drugs and cancer may reduce the risk of progressing, study suggests GLP-1 Drugs Linked to Dramatically

Terry Dubrow Says This Weight-Loss Drug Will Change Everything People lose up to 71 lbs in 68 weeksand an even more potent version is already in the works Retatrutide is so powerful, it may replace weight loss surgery for many people

According to the group of authors, these polyagonists are in all likelihood the next step towards a cure for diabetes and obesity. Comparable to bariatric surgery The authors report on various polyagonists that are currently being researched in clinical studies and show improved efficacy with each new generation. The latest triple agonists attack both the glucose-dependent insulinotropic peptide receptor (GIPR) and the receptors for glucagon-like peptide 1 (GLP1) and glucagon (GCG, a hormone from the pancreas)

Glucagon-like peptide-1 receptor expression in normal and neoplastic human pancreatic tissues

[My emphasis, but its not out of reach, maybe??] There are potential side effects though, so its not a complete home run yet

GLP-1RA Use Patterns and Discontinuation Rates The study included 201,136 incident sulfonylurea users and 132,551 incident GLP-1RA users, with a median follow-up of three years

There are several overlapping reasons: Food stays in the stomach longer, which can extend fullness